Seattle-based Shape Therapeutics raises $112M to develop RNA-editing and gene therapies by Charlotte Schubert on July 16, 2021August 24, 2021 at 9:35 am Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies, has raised $112 million. The company’s RNA editing technologies are spun out of the lab… Read More